We are excited to be a part of the 3rd Annual TriHealth Stroke and Neurosciences Conference! Chat with our expert to learn how Genomadix is revolutionizing stroke care with advanced genetic testing.

Learn more by visiting www.genomadix.com
#GenomadixCube #Stroke #MedSky #Neuro #Stroke #RapidCYP2C19

We are excited to be a part of the 3rd Annual TriHealth Stroke & Neurosciences Conference! Chat with our expert to explore how Genomadix is revolutionizing stroke care with advanced genetic testing.

Learn more by visiting www.genomadix.com
#GenomadixCube #Stroke #MedSky #Neuro #Stroke #Neuroscience

Patients on clopidogrel who are poor or intermediate metabolizers based on CYP2C19 genotype may face worse outcomes. (1) The #GenomadixCube helps clinicians guide therapy.
Learn more at www.genomadix.com

1. Lee CR et al. J Clin Pharmacol Ther. 2022;122(5):959–967

#MedSky #Neuro #NeuroSky

The FDA warns that patients with two CYP2C19 loss-of-function alleles may have reduced clopidogrel response. The #GenomadixCube provides rapid genotyping to help guide treatment and reduce risks.

Visit www.genomadix.com.

Mega JL et al. N Engl J Med. 2009;360:354–362.

#MedSky #NeuroSky #CardioSky

5 days left!
We are excited to be participating in the 2025 Florida Stroke Registry 13th Annual Stakeholder Meeting, in Tampa Bay, Florida!

Visit www.genomadix.com to explore how the Genomadix Cube can help optimize DAPT decisions!
#GenomadixCube #Stroke #MedSky #Neuro #Cardio #RapidCYP2C19

Genomadix is seeking a distribution partner to help bring the Genomadix Cube-our rapid, 1-hour CYP2C19 genetic test to clinicians across Spain.
📩 Contact Steve.Quinn@genomadix.com!

Learn more about us at www.genomadix.com
#Spain #GenomadixCube #MedSky #Neuro #Cardio #DAPT #opporunity #RapidCYP2C19

We are excited to be attending the 2025 ADLM Clinical Lab Expo in Chicago, Illinois! Chat with our experts at #DxPx Startup City, to learn about how Genomadix is revolutionizing decision diagnostics with rapid genetic testing.

Visit www.genomadix.com.

#GenomadixCube #ADLM #MedSky #Neuro #Cardio

Excited to join the 2025 Florida Stroke Registry 13th Annual Stakeholder Meeting! Don’t miss the chance to talk with Clinical Executive, Amy Parker, and learn how the Genomadix Cube is transforming stroke care. Visit www.genomadix.com.

#GenomadixCube #Stroke#MedSky #Neuro #Stroke #Cardiosky #Cardio

The #GenomadixCube is advancing personalized medicine in Italy! This article highlights how Dr. Paolo Calabró, Director of the Cardiology Unit, uses the Cube to personalize antiplatelet therapy for his patients.

Read more: lnkd.in/e-2mYzPY

Visit www.genomadix.com

#MedSky #CardioSky #NeuroSky

The #GenomadixCube delivers CYP2C19 results within the optimal DAPT window, helping clinicians personalize DAPT treatment. (1,2)
1.Kleindorfer DO, et al. Stroke. 2021;52:e364–e467.
2.Lee CR, et al. J Clinical Pharmacol Therapeutics. 2022;122(5):959-967
Visit: www.genomadix.com
#MedSky#Neuro#NeuroSky

Register and watch our Neurology Webinar for more information: “Reducing Recurrent Stroke Risk with CYP2C19 Genotype-Guided DAPT” with Neurointerventionalist Dr. Robert W. Regenhardt.
us06web.zoom.us/rec/share/Y7...

#MedSky #CardioSky #NeuroSky #Cardio #Stroke #GenomadixCube

Guided de-escalation reduces bleeding risk without raising thrombotic events.(1) Interested in rapid results? Learn more about how the #GenomadixCube can help you optimize treatment decisions by visiting: www.genomadix.com

1.van den Broek et al. JACC.2024;84:1107-1118.

#MedSky #CardioSky #NeuroSky

We are excited to be at #SCAI2025 in Washington, DC! Join us at Booth 505, May 1st-3rd, to discover how Genomadix is transforming cardiovascular care with advanced genetic testing.

Learn more at www.genomadix.com before the event!

#GenomadixCube #Cardiology #CardioSky #innovation #PCI